logo
Select company
Select metric
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - Enterprise Value over EBITDA Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - EV/EBITDA Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)Enterprise ValueEnterprise Value over EBITDA
6/30/2025$ -4.45M$ 10.65M0
3/31/2025$ -5.32M$ 13.94M0
12/31/2024$ 50.14K$ 11.45M228.37
9/30/2024$ -4.02M$ 26.15M0
6/30/2024$ -8.45M$ 17.92M0
3/31/2024$ -8.94M$ 24.94M0
12/31/2023$ -16.32M$ 14.52M0
9/30/2023$ -16.28M$ 9.16M0
6/30/2023$ -12.04M$ 21.62M0
3/31/2023$ -11.12M$ 20.46M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
  • Over the past 5 years, LIPOCINE INC's average EV/EBITDA has been 84.18.
  • The median EV/EBITDA for LIPOCINE INC during this period was 16.92
  • LIPOCINE INC reached its highest EV/EBITDA over the past 5 years at 228.37.
  • The lowest EV/EBITDA recorded by LIPOCINE INC in the same timeframe 7.24

Definition of Enterprise Value over EBITDA

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for LIPOCINE INC is calculated as follows: EV [ $ 80.38M ] / EBITDA [ $ -20.05M ]
(=) EV/EBITDA [ 0 ]

LPCN - Enterprise Value over EBITDA, Last 5 years

7.24

Minimum

Sep 30, 2022

228.37

Maximum

Dec 31, 2024

84.18

Average

16.92

Median

EV/EBITDA Benchmark Analysis

The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
filtered constituents2.44K
min0.01
max40.82
average13.48
median11.75
std7.65